A new study found that semaglutide, marketed as Ozempic and Wegovy, significantly reduces BMI in young adults with treatment-resistant severe obesity following obesity care during childhood. The…
Continue Reading
News Source: www.labroots.com

A new study found that semaglutide, marketed as Ozempic and Wegovy, significantly reduces BMI in young adults with treatment-resistant severe obesity following obesity care during childhood. The…
News Source: www.labroots.com
Leave a Reply